A Two-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Four MR Formulations and Food Effect of GW427353 (Solabegron) in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2008
At a glance
- Drugs Solabegron (Primary)
- Indications Irritable bowel syndrome; Overactive bladder
- Focus Pharmacokinetics
- 20 Feb 2007 New trial record.